| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/02/2005 | EP1501860A2 Modulation of heat-shock-protein-based immunotherapies |
| 02/02/2005 | EP1501856A2 Anti-her2 antibody variants |
| 02/02/2005 | EP1501852A2 Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 02/02/2005 | EP1501550A1 Non-viral gene delivery system |
| 02/02/2005 | EP1501545A2 Use of tnfalpha antibodies and another drug |
| 02/02/2005 | EP1501544A2 Alcam and alcam modulators |
| 02/02/2005 | EP1501543A1 Use of modified novirhabdoviruses to obtain vaccines |
| 02/02/2005 | EP1501542A1 Improved polysaccharide and glycoconjugate vaccines |
| 02/02/2005 | EP1501541A1 Encapsulated cells to elicit immune responses |
| 02/02/2005 | EP1501531A1 Method for treating anxiety and mood disorders in older subjects |
| 02/02/2005 | EP1501524A2 Internal image antibodies for optical imaging and therapy |
| 02/02/2005 | EP1501359A2 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies |
| 02/02/2005 | EP1292591B1 Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 02/02/2005 | EP1135166B9 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 02/02/2005 | EP1092040B1 Methods of inhibiting helicobacter pylori |
| 02/02/2005 | EP1064014B1 Medicament for preventing or treating papilloma virus-specific tumors |
| 02/02/2005 | EP0891420B1 Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process |
| 02/02/2005 | EP0862633B1 Virus protein antigens of the jc virus |
| 02/02/2005 | EP0757557B1 Methods for inducing t cell tolerance to a tissue or organ graft |
| 02/02/2005 | EP0741788B1 Inducing tolerance with tolerogenic fusion proteins |
| 02/02/2005 | EP0705110B1 Immunoglobulin infusion in xenotransplantation |
| 02/02/2005 | EP0613495B1 Transgenic non-human animals lacking prion proteins |
| 02/02/2005 | EP0606437B1 Non-shedding live herpesvirus vaccine |
| 02/02/2005 | CN1575339A Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins |
| 02/02/2005 | CN1575337A Mammalian receptor proteins; related reagents and methods |
| 02/02/2005 | CN1575334A Pathogen for bacterial poultry disease |
| 02/02/2005 | CN1575303A Human CDR-grafted antibodies and antibody fragments thereof |
| 02/02/2005 | CN1575302A Human tissue factor antibodies |
| 02/02/2005 | CN1575184A Method and composition for treating immune complex associated disorders |
| 02/02/2005 | CN1572875A Anti-SARS vaccine |
| 02/02/2005 | CN1572801A Double functional fusion protein possessing antineoplastic functions, method for making same and use thereof |
| 02/02/2005 | CN1572800A Specific antibody of tumor-associated antigen SM5-1 and use thereof |
| 02/02/2005 | CN1572797A Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 02/02/2005 | CN1572328A Vaccine against SARS virogene and its preparation method and use |
| 02/02/2005 | CN1572325A Treatment of lupus nephritis with anti-CD40L compounds |
| 02/02/2005 | CN1572324A Adjuvant composition |
| 02/02/2005 | CN1572323A Vaccine against SARS virogene and its construction and use |
| 02/02/2005 | CN1572322A Attenuated live neospora vaccine |
| 02/02/2005 | CN1187442C Method for transferring antigens to dendritic cells |
| 02/02/2005 | CN1187374C Humanized antibody specific for human 4-1BB and pharmaceutical compsn comprising same |
| 02/02/2005 | CN1187373C Human resourced monoclone antibody of anti-blood-vessel endothelium growth factor as well as its preparing method and medicine composition |
| 02/02/2005 | CN1187370C Connective tissue growth factor fragments and methods and uses thereof |
| 02/02/2005 | CN1187088C Chimeric flavirirus vaccines |
| 02/02/2005 | CN1187086C Hybrid with interferon alpha and immunoglobulin Fc linked through non-immunogenic peptide |
| 02/02/2005 | CN1187084C Use of alpha1 & beta1 integrin receptor inhibitors and TGF-beta1 inhibitors in the treatment of kidney disease |
| 02/01/2005 | US6849451 Hybrid cells |
| 02/01/2005 | US6849447 Protective recombinant Haemophilus influenzae high molecular weight proteins |
| 02/01/2005 | US6849446 Genetic engineering |
| 02/01/2005 | US6849438 Isolated and purified human soluble guanylyl cyclase α1/β1 (hsgcα1/β1) |
| 02/01/2005 | US6849436 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders, gout, kidney stones, Lesch-Nyhan syndrome, renal failure and uricaciduria |
| 02/01/2005 | US6849431 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| 02/01/2005 | US6849427 Dermatophagoides pteronyssinus proteins |
| 02/01/2005 | US6849420 Isolated autophosphorylating polypeptide, possessing PI3 kinase (phosphoinositide-3 kinase) activity; use drug screening for regulators of cell motility, such as antimetastasis agents |
| 02/01/2005 | US6849413 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders |
| 02/01/2005 | US6849261 CD4-independent HIV envelope proteins as vaccines and therapeutics |
| 02/01/2005 | US6849260 Methods and compositions for treating IgE-related disease using NNT-1 inhibitors |
| 02/01/2005 | CA2459622A1 Compositions and methods for restoring sensitivity to treatment with her2 antagonists |
| 02/01/2005 | CA2325351C Non-stochastic generation of genetic vaccines and enzymes |
| 02/01/2005 | CA2094261C Polypeptide of a growth factor receptor family, application in the diagnosis and treatment of myeloproliferative diseases |
| 01/28/2005 | CA2469094A1 Methods for diagnosis and therapy of cancer and composition useful therein |
| 01/27/2005 | WO2005008248A2 Diagnosis and treatment of cervical cancer |
| 01/27/2005 | WO2005007876A2 Modulation of interleukin-10 by dhea |
| 01/27/2005 | WO2005007868A2 Controlled platelet activation to monitor therapy of adp antagonists |
| 01/27/2005 | WO2005007844A1 Method of screening for agents that modulate immunophilin/peptidylproline cis-trans isomerase (ppiase)-homer interaction |
| 01/27/2005 | WO2005007831A2 Compositions of protein mimetics and methods of using same against hiv-1, sars-cov and the like |
| 01/27/2005 | WO2005007808A2 Hiv polynucleotides and polypeptides derived from botswana mj4 |
| 01/27/2005 | WO2005007804A2 Anthrax conjugate vaccine and antibodies |
| 01/27/2005 | WO2005007694A1 HER2/neu PEPTIDE AND THERAPEUTIC USE TEHREOF |
| 01/27/2005 | WO2005007691A2 East coast fever vaccine based on ctl-specific schizont antigens |
| 01/27/2005 | WO2005007690A1 Recombinant expression of streptococcus pyogenes cysteine protease and immunogenic compositions thereof |
| 01/27/2005 | WO2005007689A1 Alphavirus-based cytomegalovirus vaccines |
| 01/27/2005 | WO2005007683A1 Antigen epitopes of the regulatory protein of virulence factor in staphylococcus aureus and their mimotopes and use |
| 01/27/2005 | WO2005007674A2 Anti-human vitronectin antibody and methods for making the same |
| 01/27/2005 | WO2005007673A2 Immunogenic peptides |
| 01/27/2005 | WO2005007189A1 Subunit vaccine against respiratory syncytial virus infection |
| 01/27/2005 | WO2005007186A1 Treatment and diagnosis of neoplasms using thymic stromal lymphopoietin |
| 01/27/2005 | WO2005006864A1 Genetic vaccines for cancer therapy |
| 01/27/2005 | WO2004091656A3 Stabilising formulation for immunoglobulin g compositions in liquid form and in lyophilised form |
| 01/27/2005 | WO2004084927A3 Compositions for inducing of immunotolerance |
| 01/27/2005 | WO2004069208A3 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins |
| 01/27/2005 | WO2004067707A3 Administration of transposon-based vectors to reproductive organs |
| 01/27/2005 | WO2004060041A3 Kim-1 antagonists and use to modulate immune system |
| 01/27/2005 | WO2004050711A3 Gp120 specific antigens, conjugates thereof, methods for their preparation and uses thereof |
| 01/27/2005 | WO2004024756A3 Orthopoxvirus antigens and use thereof |
| 01/27/2005 | WO2003090687A3 Using heat shock proteins to increase immune response |
| 01/27/2005 | WO2003087374A9 Derivatives of the il-2 receptor gamma chain, their production and use. |
| 01/27/2005 | WO2003076565A3 Methods of using 46828, a human acyl-coa synthetase |
| 01/27/2005 | US20050020813 Streptococcus pneumoniae proteins and nucleic acids |
| 01/27/2005 | US20050020812 A chromatography media such as silica controlled pore glass or agarose containing an affinity ligand such as 2-Aminobenzimidazole (ABI) or aminomethylbenzimidazole (AMBI); great degree of selectivity, particularly towards proteins such as IgG |
| 01/27/2005 | US20050020548 Viricides; aids therapy |
| 01/27/2005 | US20050020528 Polynucleotide sequence coding hybrid protein; antiinflammatory agents; aids therapy; autoimmune disease |
| 01/27/2005 | US20050020520 DNA vaccine containing tumor-associated gene and cytokine gene and method of preparation the same |
| 01/27/2005 | US20050020494 Modified human growth hormone |
| 01/27/2005 | US20050020486 Product and composition containing a Concholepas concholepas hemocyanin (CCH) subunit, and a method of use thereof |
| 01/27/2005 | US20050019921 Method for combined sequential agent delivery and electroporation for cell structures and use thereof |
| 01/27/2005 | US20050019891 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 01/27/2005 | US20050019889 Human osteoclast derived cathepsin |
| 01/27/2005 | US20050019872 PC-LECTIN protein; vaccines and diagnostic marker for prostate cancer |
| 01/27/2005 | US20050019847 Using preferential antibodies to identify ubiquitin-like protein (ISG15); immunodiagnostics; wound healing agents |
| 01/27/2005 | US20050019812 Neutral amino acid transporter and gene thereof |